Showing results (1131-1140 of 1,177) with videos related to

Sort By:
Pageof 118
Nature Medicine|September 23, 2008
Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque developmentRobert L Wilensky, Yi Shi, Emile R Mohler, et al.
Frontiers in Cell and Developmental Biology|April 5, 2021
An Esrrb and Nanog Cell Fate Regulatory Module Controlled by Feed Forward Loop InteractionsAna Sevilla, Dimitri Papatsenko, Amin R Mazloom, et al.
The Lancet. Healthy Longevity|October 3, 2025
Aspirin and healthy lifespan in older people: main outcome of the ASPREE-XT observational studyRaj C Shah, Joanne Ryan, Katherine L Webb, et al.
Bioorganic & Medicinal Chemistry Letters|May 21, 2011
Synthesis and SAR studies of novel 2-(6-aminomethylaryl-2-aryl-4-oxo-quinazolin-3(4H)-yl)acetamide vasopressin V1b receptor antagonistsSusan E Napier, Jeffrey J Letourneau, Nasrin Ansari, et al.
Journal of Medicinal Chemistry|January 31, 2013
A novel class of oral direct renin inhibitors: highly potent 3,5-disubstituted piperidines bearing a tricyclic p3-p1 pharmacophoreNils Ostermann, Simon Ruedisser, Claus Ehrhardt, et al.
Biorxiv : the Preprint Server for Biology|March 18, 2026
Evaluation of an H5 influenza virus mRNA-lipid nanoparticle (LNP) vaccine in lactating dairy cowsJefferson J S Santos, Carine K Souza, Giovana C Zanella, et al.
The Lancet. Global Health|October 18, 2024
The effect of intensive praziquantel administration on vaccine-specific responses among schoolchildren in Ugandan schistosomiasis-endemic islands (POPVAC A): an open-label, randomised controlled trialGyaviira Nkurunungi, Jacent Nassuuna, Agnes Natukunda, et al.
Immunotherapy Advances|August 4, 2023
Establishing a single-sex controlled human Schistosoma mansoni infection model for Uganda: protocol for safety and dose-finding trialAndrew Abaasa, Moses Egesa, Emmanuella Driciru, et al.
The Lancet. Global Health|October 18, 2024
The effect of intermittent preventive treatment for malaria with dihydroartemisinin-piperaquine on vaccine-specific responses among schoolchildren in rural Uganda (POPVAC B): a double-blind, randomised controlled trialLudoviko Zirimenya, Agnes Natukunda, Jacent Nassuuna, et al.
Nature Medicine|July 1, 2026
Multi-antigen-targeting T cells in pediatric central nervous system tumors: a phase 1 trialStephanie Gomez, Rachel A DiCioccio, Ashley E Geiger, et al.
Pageof 118